|
|||||
|
|
Baseline characteristics predict risk of progression and response to combined medical therapy for benign prostatic hyperplasia (BPH) |
|
| Authors: | Michael A. Kozminski John T. Wei Jason Nelson David M. Kent |
| Affiliation: | 1. Department of Urology, University of Michigan Medical School, Ann Arbor, MI, USA;2. Predictive Analytics and Comparative Effectiveness Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center/Tufts University School of Medicine, Boston, USA |
| Abstract: | |
| Keywords: | benign prostatic hyperplasia (BPH) lower urinary tract symptoms (LUTS) risk factors |